INGENIA Therapeutics950260

Largest holderAurum Asset Management19.68%$144M

Filed holders175% or more, plus insiders

Price and institutional trades

1Y 2Y

$14.75+10.7%1Y

DecJanFebMarAprMayJunJulAugSepOctNov

Holders

Aurum Asset ManagementInsider report$144M · 2026-08-2519.68%

Han Sang-yeul$118M · 2026-09-2916.23%

INTERVEST Open Innovation Private Equity Fund$89M · 2026-09-2912.16%

$86M · 2026-09-2911.79%

$58M · 2026-09-297.89%

$47M · 2026-09-296.47%

$31M · 2026-09-294.30%

$19M · 2026-09-292.60%

$16M · 2026-09-292.24%

$15M · 2026-09-292.05%

$15M · 2026-09-292.03%

$15M · 2026-09-292.02%

$12M · 2026-09-291.59%

$11M · 2026-09-291.58%

$8.4M · 2026-09-291.15%

2 other related parties$3.7M0.50%

Average cost is the mean purchase price from filings since November 2024. Indirect stakes multiply ownership through listed companies.

Filings

Filed	Changed	Before → after	Amount	Avg buy price
2026-09-29	2026-09-29	76.80 → 74.60%	−$17M	-	Filing
2026-08-25	-	12.16%	-	-	Filing
2026-08-25	-	19.68%	-	-	Filing
2026-08-25	-	2.05%	-	-	Filing
2026-08-25	-

6 in the last 2 years · amount = quantity × price per trade in the last year (closing price where no price is filed), avg buy price = average of buys in that filing · change dates and prices only where the original filing was fetched